97 related articles for article (PubMed ID: 19307009)
21. HPV E6 targeted degradation of the discs large protein: evidence for the involvement of a novel ubiquitin ligase.
Pim D; Thomas M; Javier R; Gardiol D; Banks L
Oncogene; 2000 Feb; 19(6):719-25. PubMed ID: 10698489
[TBL] [Abstract][Full Text] [Related]
22. Structural insights into a wildtype domain of the oncoprotein E6 and its interaction with a PDZ domain.
Mischo A; Ohlenschläger O; Hortschansky P; Ramachandran R; Görlach M
PLoS One; 2013; 8(4):e62584. PubMed ID: 23638119
[TBL] [Abstract][Full Text] [Related]
23. Chimaeric HPV E6 proteins allow dissection of the proteolytic pathways regulating different E6 cellular target proteins.
Pim D; Thomas M; Banks L
Oncogene; 2002 Nov; 21(53):8140-8. PubMed ID: 12444549
[TBL] [Abstract][Full Text] [Related]
24. Design of a PDZbody, a bivalent binder of the E6 protein from human papillomavirus.
Karlsson OA; Ramirez J; Öberg D; Malmqvist T; Engström Å; Friberg M; Chi CN; Widersten M; Travé G; Nilsson MT; Jemth P
Sci Rep; 2015 Mar; 5():9382. PubMed ID: 25797137
[TBL] [Abstract][Full Text] [Related]
25. An internal class III PDZ binding motif in HPV16 E6* protein is required for Dlg degradation activity.
Umnajvijit W; Sangthong J; Loison F; Vaeteewoottacharn K; Ponglikitmongkol M
Biochim Biophys Acta Gen Subj; 2021 May; 1865(5):129850. PubMed ID: 33486056
[TBL] [Abstract][Full Text] [Related]
26. PDZ domains and viral infection: versatile potentials of HPV-PDZ interactions in relation to malignancy.
Nagasaka K; Kawana K; Osuga Y; Fujii T
Biomed Res Int; 2013; 2013():369712. PubMed ID: 24093094
[TBL] [Abstract][Full Text] [Related]
27. Human papillomaviruses, cervical cancer and cell polarity.
Thomas M; Narayan N; Pim D; Tomaić V; Massimi P; Nagasaka K; Kranjec C; Gammoh N; Banks L
Oncogene; 2008 Nov; 27(55):7018-30. PubMed ID: 19029942
[TBL] [Abstract][Full Text] [Related]
28. Mutational analysis of the discs large tumour suppressor identifies domains responsible for human papillomavirus type 18 E6-mediated degradation.
Gardiol D; Galizzi S; Banks L
J Gen Virol; 2002 Feb; 83(Pt 2):283-289. PubMed ID: 11807220
[TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus (HPV)-18 E6 oncoprotein interferes with the epithelial cell polarity Par3 protein.
Facciuto F; Bugnon Valdano M; Marziali F; Massimi P; Banks L; Cavatorta AL; Gardiol D
Mol Oncol; 2014 May; 8(3):533-43. PubMed ID: 24462519
[TBL] [Abstract][Full Text] [Related]
30. In vitro assays of substrate degradation induced by high-risk HPV E6 oncoproteins.
Thomas M; Banks L
Methods Mol Med; 2005; 119():411-7. PubMed ID: 16350414
[TBL] [Abstract][Full Text] [Related]
31. CDK phosphorylation of the discs large tumour suppressor controls its localisation and stability.
Narayan N; Massimi P; Banks L
J Cell Sci; 2009 Jan; 122(Pt 1):65-74. PubMed ID: 19066288
[TBL] [Abstract][Full Text] [Related]
32. The human papillomavirus (HPV) E6* proteins from high-risk, mucosal HPVs can direct degradation of cellular proteins in the absence of full-length E6 protein.
Pim D; Tomaic V; Banks L
J Virol; 2009 Oct; 83(19):9863-74. PubMed ID: 19640984
[TBL] [Abstract][Full Text] [Related]
33. Proteolysis of the tumour suppressor hDlg in response to osmotic stress is mediated by caspases and independent of phosphorylation.
Iñesta-Vaquera FA; Centeno F; del Reino P; Sabio G; Peggie M; Cuenda A
FEBS J; 2009 Jan; 276(2):387-400. PubMed ID: 19054065
[TBL] [Abstract][Full Text] [Related]
34. The hScrib/Dlg apico-basal control complex is differentially targeted by HPV-16 and HPV-18 E6 proteins.
Thomas M; Massimi P; Navarro C; Borg JP; Banks L
Oncogene; 2005 Sep; 24(41):6222-30. PubMed ID: 16103886
[TBL] [Abstract][Full Text] [Related]
35. Expression of TMEM87B interacting with the human papillomavirus type 18 E6 oncogene in the Hela cDNA library by a yeast two-hybrid system.
Li S; Liu P; Xi L; Jiang X; Wu M; Deng D; Wei J; Zhu T; Zhou L; Wang S; Xu G; Meng L; Zhou J; Ma D
Oncol Rep; 2008 Aug; 20(2):421-7. PubMed ID: 18636207
[TBL] [Abstract][Full Text] [Related]
36. Proteasome-mediated regulation of the hDlg tumour suppressor protein.
Mantovani F; Massimi P; Banks L
J Cell Sci; 2001 Dec; 114(Pt 23):4285-92. PubMed ID: 11739660
[TBL] [Abstract][Full Text] [Related]
37. PDZRN3/LNX3 is a novel target of human papillomavirus type 16 (HPV-16) and HPV-18 E6.
Thomas M; Banks L
J Virol; 2015 Jan; 89(2):1439-44. PubMed ID: 25355882
[TBL] [Abstract][Full Text] [Related]
38. Acquisition of a phospho-acceptor site enhances HPV E6 PDZ-binding motif functional promiscuity.
Sarabia-Vega V; Banks L
J Gen Virol; 2020 Sep; 101(9):954-962. PubMed ID: 30810519
[TBL] [Abstract][Full Text] [Related]
39. High-risk human papillomavirus E6 oncoproteins interact with 14-3-3ζ in a PDZ binding motif-dependent manner.
Boon SS; Banks L
J Virol; 2013 Feb; 87(3):1586-95. PubMed ID: 23175360
[TBL] [Abstract][Full Text] [Related]
40. Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein.
Lee SS; Weiss RS; Javier RT
Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6670-5. PubMed ID: 9192623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
